John Casement Dr Gordon Strathdee Professor Mark Pearce
| Epigenome-wide analysis across the development span of pediatric acute lymphoblastic leukemia: backtracking to birth | 2024 |
|
Chalermsin Permtermsin - Lalchungnunga Dr Sirintra Nakjang John Casement Dr Laura Ogle et al. | Identification of TIAM1 as a Potential Synthetic-Lethal-like Gene in a Defined Subset of Hepatocellular Carcinoma | 2023 |
|
Natassia Robinson John Casement Professor Roderick Skinner Professor Linda Sharp Dr Jill McKay et al. | Anti-cancer therapy is associated with long-term epigenomic changes in childhood cancer survivors | 2022 |
|
Wen Hao Professor Deborah Tweddle Dr Ed Schwalbe Dr Gordon Strathdee
| Genome wide DNA methylation analysis identifies novel molecular subgroups and predicts survival in neuroblastoma | 2022 |
|
Dr Timothy Barrow Dr Elaine Willmore Dr Gordon Strathdee Dr Hyang-Min Byun
| Analysis of retrotransposon subfamily DNA methylation reveals novel early epigenetic changes in chronic lymphocytic leukaemia | 2021 |
|
Dr Timothy Barrow Dr Sirintra Nakjang Kateryna Bilotkach Dr Laura Woodhouse Gesa Junge et al. | Epigenome-wide analysis reveals functional modulators of drug sensitivity and post-treatment survival in chronic lymphocytic leukaemia | 2021 |
|
Dr Wei-Yu Lin Dr Sarah Fordham Dr Nicola Sunter Dr Claire Elstob Dr Thahira Rahman et al. | Genome-wide association study identifies risk loci for progressive chronic lymphocytic leukemia | 2021 |
|
Dr Ed Schwalbe - Lalchungnunga Dr Timothy Barrow Dr Gordon Strathdee
| Integration of genome-level data to allow identification of subtype-specific vulnerability genes as novel therapeutic targets | 2021 |
|
Professor Judith Rankin Dr Gordon Strathdee Dr Jill McKay
| Exploring a potential mechanistic role of DNA methylation in the relationship between in utero and post-natal environmental exposures and risk of childhood acute lymphoblastic leukaemia | 2019 |
|
Dr Kate Potter Professor Anthony Moorman Professor Caroline Relton Professor John Mathers Dr Gordon Strathdee et al. | Maternal red blood cell folate and infant vitamin B12 status influence methylation of genes associated with childhood acute lymphoblastic leukaemia | 2018 |
|
Jessica Timms Professor Caroline Relton Professor Judith Rankin Dr Gordon Strathdee Dr Jill McKay et al. | DNA methylation as a potential mediator of environmental risks in the development of childhood acute lymphoblastic leukaemia | 2016 |
|
Dr Timothy Barrow Dr Laura Woodhouse Gesa Junge Dr Susan Tudhope Dr Jonathan Wallis et al. | The Role of HOXA4 in Chronic Lymphocytic Leukaemia Progression and Response to Therapy | 2016 |
|
Sanne van Otterdijk Jean Norden Professor Anne Dickinson Professor Mark Pearce Professor Caroline Relton et al. | Aberrations in DNA methylation are detectable during remission of acute lymphoblastic leukemia and predict patient outcome | 2015 |
|
Dr Chris Smart Dr Gordon Strathdee Dr Stuart Watson Professor Hamish McAllister-Williams
| Early life trauma, depression and the glucocorticoid receptor gene - an epigenetic perspective | 2015 |
|
Dr Al Gabriel Fadhel Alsaid Naji Dr Ed Schwalbe Dr Sirintra Nakjang Dr Simon Cockell et al. | Epigenetic landscape correlates with genetic subtype but does not predict outcome in childhood acute lymphoblastic leukemia | 2015 |
|
Dr Joanna Collerton Hannah Gautrey Sanne van Otterdijk Dr Karen Davies Dr Carmen Martin-Ruiz et al. | Acquisition of aberrant DNA methylation is associated with frailty in the very old: findings from the Newcastle 85+Study | 2014 |
|
Hannah Gautrey Sanne van Otterdijk Professor Heather Cordell Professor John Mathers Dr Gordon Strathdee et al. | DNA methylation abnormalities at gene promoters are extensive and variable in the elderly and phenocopy cancer cells | 2014 |
|
Fadhel Alsaid Naji Dr Vikki Rand Professor Anthony Moorman Dr Ed Schwalbe Dr Amir Enshaei et al. | Investigation of methylation based biomarkers for prediction of relapse in good prognostic cytogenetic subgroups of childhood acute lymphoblastic leukaemia | 2014 |
|
Sanne van Otterdijk Professor John Mathers Dr Gordon Strathdee
| Do age-related changes in DNA methylation play a role in the development of age-related diseases? | 2013 |
|
Shabnam Thathia Stuart Ferguson Hannah Gautrey Sanne Van Otterdijk Dr Vikki Rand et al. | Epigenetic inactivation of TWIST2 in acute lymphoblastic leukemia modulates proliferation, cell survival and chemosensitivity | 2012 |
|
Dr Tryfonia Mainou-Fowler Dr Gordon Strathdee
| Methylation markers identify high risk patients in IGHV mutated chronic lymphocytic leukemia | 2011 |
|
Dr Gordon Strathdee
| Methylation markers in the clinical management of leukemia patients – Wave of the future or damp squib? | 2011 |
|
Stuart Ferguson Hannah Gautrey Dr Gordon Strathdee
| The Dual Role of HLXB9 in Leukemia | 2011 |
|
Dr Gordon Strathdee Stuart Ferguson
| DNA methylation does not regulate JUNB expression in CML: Comment on "Downregulation of JUNB mRNA expression in advanced phase chronic myelogenous leukemia" by Hoshino et al. [Leuk. Res. 33 (2009) 1361-1366] | 2010 |
|
Professor John Mathers Dr Gordon Strathdee Professor Caroline Relton
| Induction of Epigenetic Alterations by Dietary and Other Environmental Factors | 2010 |
|
Dr Gordon Strathdee
| HOXA5 is targeted by cell-type-specific CpG island methylation in normal cells and during the development of acute myeloid leukaemia | 2007 |
|
Dr Gordon Strathdee
| Epigenetic markers and response to chemotherapy in cancer | 2007 |
|
Dr Gordon Strathdee Professor Anne Dickinson
| HOX genes - Candidate tumor suppressor genes in adult, and childhood leukemia. | 2007 |
|
Dr Gordon Strathdee Professor Anne Dickinson
| HOX genes are a major target for epigenetic mis-regulation in adult and childhood leukaemia | 2007 |
|
Dr Gordon Strathdee Professor Anne Dickinson
| Inactivation of HOXA genes by hypermethylation in myeloid and lymphoid malignancy is frequent and associated with poor prognosis | 2007 |
|
Dr Gordon Strathdee Dr Laura Mackay
| Phase I and pharmacodynamic trial of the DNA methyltransferase inhibitor decitabine and carboplatin in solid tumors. | 2007 |
|
Dr Janet Lindsey Dr Meryl Lusher Dr Gordon Strathdee Robert Brown Dr Richard Gilbertson et al. | Epigenetic inactivation of MCJ (DNAJD1) in malignant paediatric brain tumours | 2006 |
|
Dr Janet Lindsey Dr Meryl Lusher Dr Gordon Strathdee Dr Richard Gilbertson Professor Simon Bailey et al. | Epigenetic inactivation of MCJ (DNAJD1) in malignant paediatric brain tumours | 2006 |
|
Dr Gordon Strathdee
| Promoter hypermethylation silences expression of the HoxA4 gene and correlates with IgVh mutational status in CLL | 2006 |
|
Dr Gordon Strathdee
| CpG island methylation of DNA damage response genes in advanced ovarian cancer | 2005 |
|
Dr Gordon Strathdee
| Demethylation of the MCJ gene in stage III/IV epithelial ovarian cancer and response to chemotherapy | 2005 |
|
Dr Gordon Strathdee
| Bioscience 2004 | 2004 |
|
Dr Gordon Strathdee Dr Barry Davies
| Cell type-specific methylation of an intronic CpG island controls expression of the MCJ gene | 2004 |
|
Dr Gordon Strathdee
| Control of gene expression by CpG island methylation in normal cells | 2004 |
|
Dr Gordon Strathdee
| CpG-island methylation and epigenetic control of resistance to chemotherapy | 2004 |
|
Dr Gordon Strathdee
| Epigenetic silencing mediated by CpG island methylation: potential as a therapeutic target and as a biomarker | 2004 |
|
Dr Gordon Strathdee
| Aberrant DNA methylation in cancer: potential clinical interventions | 2002 |
|
Dr Gordon Strathdee
| Epigenetic cancer therapies: DNA methyltransferase inhibitors | 2002 |
|
Dr Gordon Strathdee
| Epigenetic versus genetic alterations in the inactivation of E-cadherin | 2002 |
|
Dr Gordon Strathdee
| Epigenomics and epigenetic therapy of cancer | 2002 |
|
Dr Gordon Strathdee
| Methylation microarray analysis of late-stage ovarian carcinomas distinguishes progression-free survival in patients and identifies candidate epigenetic markers | 2002 |
|
Dr Gordon Strathdee
| A role for mismatch repair in control of DNA ploidy following DNA damage | 2001 |
|
Dr Gordon Strathdee
| Primary Ovarian Carcinomas Display Multiple Methylator Phenotypes Involving Known Tumor Suppressor Genes | 2001 |
|
Dr Gordon Strathdee Julieann Sludden
| Reversal of drug resistance in human tumor xenografts by 2'-deoxy-5-azacytidine-induced demethylation of the hMLH1 gene promoter | 2000 |
|
Dr Gordon Strathdee
| A role for methylation of the hMLH1 promoter in loss of hMLH1 expression and drug resistance in ovarian cancer | 1999 |
|
Dr Gordon Strathdee
| Analysis of the CAVEOLIN-1 gene at human chromosome 7q31.1 in primary tumours and tumour-derived cell lines | 1999 |
|